Kenneth Obi, MD
Gastroenterology · Rome, GANPI 1184853053
Payments from drug & device makers
Across 836 payments — averaging $40.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Phathom Pharmaceuticals, Inc.$13K
- E.r. Squibb & Sons, L.L.C.$5K
- AbbVie$5K
- Bristol Myers Squibb$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$979
- plus $6K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 32 | $13,325 |
| E.r. Squibb & Sons, L.L.C. | 2 | $4,755 |
| AbbVie(2 entities) | 261 | $4,724 |
| Bristol Myers Squibb | 53 | $1,883 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 107 | $1,771 |
| Takeda Pharmaceuticals U.S.A., Inc. | 56 | $979 |
| Sanofi | 35 | $899 |
| Johnson & Johnson(2 entities) | 49 | $885 |
| Gilead | 47 | $805 |
| Pfizer | 45 | $709 |
| Intercept Pharmaceuticals, Inc. | 30 | $528 |
| Regeneron Healthcare Solutions, Inc. | 17 | $411 |
| Ironwood Pharmaceuticals, Inc | 21 | $300 |
| Madrigal Pharmaceuticals | 9 | $231 |
| Nestle Healthcare Nutrition Inc. | 11 | $174 |
| Ferring Pharmaceuticals Inc. | 9 | $167 |
| Ipsen Biopharmaceuticals, Inc | 8 | $167 |
| Medtronic | 8 | $130 |
| Ardelyx, Inc. | 6 | $119 |
| Aimmune Therapeutics, Inc. | 4 | $76 |
| Alfasigma USA, Inc. | 5 | $73 |
| UCB, Inc. | 3 | $57 |
| Olympus America Inc. | 2 | $54 |
| Vivus LLC | 3 | $51 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 |
| Covidien LP | 1 | $30 |
| Intra-sana Laboratories | 2 | $29 |
| Romark Laboratories, LC | 2 | $26 |
| Boston Scientific | 1 | $23 |
| Redhill Biopharma Inc. | 1 | $17 |
| Evoke Pharma, Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Braintree Laboratories, Inc. | 1 | $14 |
| Dova Pharmaceuticals | 1 | $12 |
How this compares
$33,499 in reported general payments places this provider in the 90th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Rome
- Douglas WolfAtlanta$6.4M
- Aasim SheikhMarietta$6M
- Shahriar SedghiMacon$5.4M
- Jeffrey WilliamsAthens$2.5M
- Michael GalambosAtlanta$1.8M
- Nitin GuptaAtlanta$1.7M
- Bruce SalzbergSuwanee$1.4M
- Heba IskandarAtlanta$978K
- David RausherDecatur$907K
- Florence Hosseini AsliniaHiram$885K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.